Cargando…

Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas

Rationale: Oncogenic STAT3 signaling activation and 3p22-21.3 locus alteration are common in multiple tumors, especially carcinomas of the nasopharynx, esophagus and lung. Whether these two events are linked remains unclear. Our CpG methylome analysis identified a 3p22.2 gene, DLEC1, as a methylated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lili, Xu, Juan, Qiu, Guohua, Ying, Jianming, Du, Zhenfang, Xiang, Tingxiu, Wong, Kai Yau, Srivastava, Gopesh, Zhu, Xiao-Feng, Mok, Tony S, Chan, Anthony TC, Chan, Francis KL, Ambinder, Richard F, Tao, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743460/ https://www.ncbi.nlm.nih.gov/pubmed/29290793 http://dx.doi.org/10.7150/thno.20893

Ejemplares similares

Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum
por: Li, Lili, et al.
Publicado: (2022)

Epigenomic and Functional Characterization of Junctophilin 3 (JPH3) as a Novel Tumor Suppressor Being Frequently Inactivated by Promoter CpG Methylation in Digestive Cancers
por: Hu, Xiaotong, et al.
Publicado: (2017)

Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas
por: Wang, Zhaohui, et al.
Publicado: (2012)

Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma
por: Chen, Juan, et al.
Publicado: (2012)

Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers
por: Li, Lili, et al.
Publicado: (2016)

Corrigendum: Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers
por: Li, Lili, et al.
Publicado: (2016)

OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
por: Cui, Yan, et al.
Publicado: (2008)

The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/β-Catenin Signaling and Is Frequently Silenced in Multiple Tumors
por: Shu, Xing-sheng, et al.
Publicado: (2011)

Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
por: Cui, Yan, et al.
Publicado: (2008)

Inhibition of miRNA-222-3p Relieves Staphylococcal Enterotoxin B-Induced Liver Inflammatory Injury by Upregulating Suppressors of Cytokine Signaling 1
por: Zhang, Peng, et al.
Publicado: (2019)

The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer
por: Shao, Bianfei, et al.
Publicado: (2017)

Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis
por: Takigawa, Shinya, et al.
Publicado: (2016)

High expression of miR-222-3p in children with Mycoplasma pneumoniae pneumonia
por: Chu, Chu, et al.
Publicado: (2019)

Emerging roles and mechanisms of microRNA-222-3p in human cancer (Review)
por: Wang, Danhua, et al.
Publicado: (2021)

miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer
por: Mei, Yu, et al.
Publicado: (2021)

Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma
por: He, Ya, et al.
Publicado: (2019)

The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation
por: Luo, Xinrong, et al.
Publicado: (2017)

miR-222-3p promotes osteosarcoma cell migration and invasion through targeting TIMP3
por: Guo, Jianping, et al.
Publicado: (2018)

Deficiency of emerin contributes differently to the pathogenesis of skeletal and cardiac muscles in Lmna(H222P/H222P) mutant mice
por: Wada, Eiji, et al.
Publicado: (2019)

The inverted pattern of circulating miR-221-3p and miR-222-3p associated with isolated low HDL-C phenotype
por: Zhou, Yuntao, et al.
Publicado: (2018)

Human artificial chromosome carrying 3p21.3-p22.2 region suppresses hTERT transcription in oral cancer cells
por: Ohira, Takahito, et al.
Publicado: (2023)

Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer
por: Sun, Yu, et al.
Publicado: (2021)

P222: Period vs point prevalence – what is the difference?
por: Zingg, W, et al.
Publicado: (2013)

7p22.2 Microduplication: A Pathogenic CNV?
por: Bauleo, Alessia, et al.
Publicado: (2023)

miR-221-3p and miR-222-3p regulate the SOCS3/STAT3 signaling pathway to downregulate the expression of NIS and reduce radiosensitivity in thyroid cancer
por: Ye, Ting, et al.
Publicado: (2021)

MiR-222-3p in Platelets Serves as a Distinguishing Marker for Early Recognition of Kawasaki Disease
por: Wang, Bo, et al.
Publicado: (2019)

Prognostic and Immune-Infiltrate Significance of miR-222-3p and Its Target Genes in Thyroid Cancer
por: Zhang, Taofeng, et al.
Publicado: (2021)

Hotair promotes the migration and proliferation in ovarian cancer by miR-222-3p/CDK19 axis
por: Fan, Lili, et al.
Publicado: (2022)

Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer
por: Yin, Xuedong, et al.
Publicado: (2016)

p53: master of life, death, and the epigenome
por: Laptenko, Oleg, et al.
Publicado: (2017)

MiR-222-3p Aggravates the Inflammatory Response by Targeting SOCS1 to Activate STAT3 Signaling in Ulcerative Colitis
por: Xia, Fei, et al.
Publicado: (2022)

miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: de la Cruz-Ojeda, Patricia, et al.
Publicado: (2022)

The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway
por: Liu, Juan, et al.
Publicado: (2020)

Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

NRG1 is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene
por: Chua, Y-L, et al.
Publicado: (2008)

Elevated MiR-222-3p Promotes Proliferation and Invasion of Endometrial Carcinoma via Targeting ERα
por: Liu, Binya, et al.
Publicado: (2014)

Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages
por: Ying, Xiang, et al.
Publicado: (2016)

Targeting of CDKN1B by miR‐222‐3p may contribute to the development of intervertebral disc degeneration
por: Liu, Jianwei, et al.
Publicado: (2019)

Curcumin Inhibits the Growth and Metastasis of Melanoma via miR-222-3p/SOX10/Notch Axis
por: Tang, Youqun, et al.
Publicado: (2022)

Kukoamine A Improves Mycoplasma pneumoniae Pneumonia by Regulating miR-222-3p/Superoxide Dismutase 2
por: Liu, Xiu-Xiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sddk43d2qmbsd1on0rhc5d8mat